ZNTL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Zentalis Pharmaceuticals Inc (ZNTL) is not a good buy for a beginner investor with a long-term strategy at this time. The company's financial performance is weak, with declining revenue, net income, and EPS. Technical indicators are mixed, showing no strong bullish signals, and there are no positive catalysts or significant trading trends to support a buy decision. Additionally, options data and stock trend analysis suggest bearish sentiment in the short term.
The MACD is below 0 and negatively contracting, indicating weak momentum. RSI is neutral at 52.639, showing no clear signal. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is trading close to its pivot level (2.458), with resistance at 2.624 and support at 2.292. Overall, technical indicators are mixed and do not strongly support a buy decision.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
Stock trend analysis indicates a high probability of short-term declines (-5.39% in the next day, -10.1% in the next week, -9.72% in the next month).
In Q3 2025, revenue remained at 0 with no growth. Net income dropped by -33.54% YoY to -$26.69 million. EPS declined by -33.93% YoY to -$0.37. Gross margin fell to 0, down -100% YoY, reflecting poor financial health and profitability.
No recent analyst ratings or price target changes available.
